Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

China Cord Blood Corporation (CO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 750,440
  • Shares Outstanding, K 73,000
  • Annual Sales, $ 110,410 K
  • Annual Income, $ 18,330 K
  • 36-Month Beta 0.89
  • Price/Sales 6.68
  • Price/Cash Flow 32.83
  • Price/Book 2.75

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.11 +12.84%
on 06/22/17
10.51 -2.19%
on 07/12/17
+1.19 (+13.09%)
since 06/21/17
3-Month
6.72 +52.98%
on 04/24/17
10.51 -2.19%
on 07/12/17
+3.43 (+50.07%)
since 04/21/17
52-Week
4.27 +140.75%
on 12/16/16
10.51 -2.19%
on 07/12/17
+4.72 (+84.89%)
since 07/21/16

Most Recent Stories

More News
Featured Company News - Thermo Fisher's Companion Diagnostic Test to Screen Multiple Non-Small Cell Lung Cancer Gets Pre-market Approval from US FDA

Research Desk Line-up: China Cord Blood Post Earnings Coverage

TMO : 182.18 (+0.35%)
CO : 10.28 (+1.78%)
China Cord Blood Corporation achieves better net income of CNY126.2m for fiscal 2017

Cord blood company China Cord Blood Corporation (NYSE:CO) stated on Wednesday that its net income was CNY126.2m for full year of the fiscal year 2017 ended 31 March 2017.

CO : 10.28 (+1.78%)
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2017

Added 20,566 New Subscribers in 4Q17

CO : 10.28 (+1.78%)
China Cord Blood Has Returned 63.4% Since SmarTrend Recommendation (CO)

SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on December 14th, 2016 at $5.20. In approximately 6 months, China Cord Blood has returned 63.43% as of today's recent price of $8.49.

CO : 10.28 (+1.78%)
China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2017 Financial Results

Earnings Call Scheduled for 8:00 a.m. ET on June 22, 2017

CO : 10.28 (+1.78%)
Uptrend Call Working As China Cord Blood Stock Rises 63.0% (CO)

SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on December 14th, 2016 at $5.20. In approximately 6 months, China Cord Blood has returned 63.04% as of today's recent price of $8.47.

CO : 10.28 (+1.78%)
Umbilical Cord Blood Banking Market to Reach US$8,178.1 Million by 2025: Rising Applications of Cord Blood Cells in Treatment of Chronic Diseases Driving Adoption

The vendor landscape of the global Umbilical Cord Blood Banking Market is highly fragmented owing to the presence of several small scale vendors, with the top three vendors collectively accounting for...

CLIFF : 0.6900 (unch)
CBAI : 0.0038 (+2.70%)
CO : 10.28 (+1.78%)
China Cord Blood Set to Possibly Pullback After Yesterday's Rally of 1.12%

China Cord Blood (NYSE:CO) traded in a range yesterday that spanned from a low of $8.03 to a high of $8.88. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $8.49...

CO : 10.28 (+1.78%)
54.4% Return Seen to Date on SmarTrend China Cord Blood Call (CO)

SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on December 14th, 2016 at $5.20. In approximately 5 months, China Cord Blood has returned 54.38% as of today's recent price of $8.02.

CO : 10.28 (+1.78%)
China Cord Blood Up 40.7% Since SmarTrend Uptrend Call (CO)

SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on December 14th, 2016 at $5.20. In approximately 5 months, China Cord Blood has returned 40.71% as of today's recent price of $7.31.

CO : 10.28 (+1.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with more than one license (i.e., Beijing and Guangdong). Under the current PRC government regulations, only one licensed cord blood...

See More

Support & Resistance

2nd Resistance Point 10.54
1st Resistance Point 10.41
Last Price 10.28
1st Support Level 10.09
2nd Support Level 9.90

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.